Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALEMTUZUMAB”

245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 245 results

Early research (Phase 1)Study completedNCT02583594
What this trial is testing

Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Genzyme, a Sanofi Company 24
Testing effectiveness (Phase 2)Ended earlyNCT00167661
What this trial is testing

Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
University of Wisconsin, Madison 33
Testing effectiveness (Phase 2)Study completedNCT01082939
What this trial is testing

Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 80
Post-approval studies (Phase 4)Ended earlyNCT00166712
What this trial is testing

A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression

Who this might be right for
Kidney Transplant Failure and Rejection
Northwestern University 40
Testing effectiveness (Phase 2)Study completedNCT02472054
What this trial is testing

Treatment of Familiar Lymphohistiocytosis

Who this might be right for
Hemophagocytic Lymphohistiocytosis (HLH)
Assistance Publique - Hôpitaux de Paris 29
Large-scale testing (Phase 3)Study completedNCT00354120
What this trial is testing

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

Who this might be right for
Acute Myeloblastic LeukemiaLymphoblastic LeukemiaMyelodysplasia+3 more
Gruppo Italiano Trapianto di Midollo Osseo 121
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Testing effectiveness (Phase 2)Study completedNCT00930605
What this trial is testing

The Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)

Who this might be right for
Peripheral T-cell Lymphoma
King Chulalongkorn Memorial Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00162851
What this trial is testing

Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-CLL
Karolinska University Hospital 20
Not applicableStudy completedNCT03302754
What this trial is testing

Precision Dosing of Alemtuzumab

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, Cincinnati 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT01659606
What this trial is testing

Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

Who this might be right for
Dyskeratosis CongenitaHoyeraal Hreidarsson SyndromeRevesz Syndrome+1 more
Boston Children's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00260689
What this trial is testing

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

Who this might be right for
ImmunosuppresionThrombocytopeniaPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI) 136
Testing effectiveness (Phase 2)Study completedNCT00078559
What this trial is testing

Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

Who this might be right for
Kidney TransplantationKidney Disease
University of Wisconsin, Madison 10
Testing effectiveness (Phase 2)Study completedNCT00328198
What this trial is testing

Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia (B-CLL)
Genzyme, a Sanofi Company 86
Testing effectiveness (Phase 2)Looking for participantsNCT07599176
What this trial is testing

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Who this might be right for
Sickle Cell DiseaseBeta-thalassemia
National Heart, Lung, and Blood Institute (NHLBI) 90
Early research (Phase 1)Study completedNCT00495755
What this trial is testing

Campath in Chronic GVHD

Who this might be right for
Chronic Graft-vs.-Host Disease
Dana-Farber Cancer Institute 13
Testing effectiveness (Phase 2)UnknownNCT01446484
What this trial is testing

Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

Who this might be right for
End-Stage Renal DiseaseKidney Failure
Pirogov Russian National Research Medical University 30
Testing effectiveness (Phase 2)Study completedNCT00274976
What this trial is testing

Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine

Who this might be right for
Leukemia
German CLL Study Group
Testing effectiveness (Phase 2)UnknownNCT00908180
What this trial is testing

Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Lymphoma
Cancer Research UK 47
Testing effectiveness (Phase 2)Study completedNCT00692562
What this trial is testing

Simultaneous Islet-Kidney Transplantation in Patients of Type 1 Diabetes With End-stage Renal Disease

Who this might be right for
Type 1 Diabetes MellitusEnd-stage Renal Disease
Fuzhou General Hospital 7
Next Page